T. Rowe Price Associates’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $790K | Sell |
342,815
-7,089
| -2% | -$16.3K | ﹤0.01% | 2087 |
|
|
2025
Q1 | $1.52M | Buy |
349,904
+11,375
| +3% | +$49.3K | ﹤0.01% | 1740 |
|
|
2024
Q4 | $644K | Buy |
338,529
+98,377
| +41% | +$187K | ﹤0.01% | 2164 |
|
|
2024
Q3 | $945K | Sell |
240,152
-800,569
| -77% | -$3.15M | ﹤0.01% | 1993 |
|
|
2024
Q2 | $6.81M | Sell |
1,040,721
-625,041
| -38% | -$4.09M | ﹤0.01% | 1169 |
|
|
2024
Q1 | $10.2M | Sell |
1,665,762
-8,474,124
| -84% | -$51.7M | ﹤0.01% | 1103 |
|
|
2023
Q4 | $127M | Buy |
10,139,886
+3,195,087
| +46% | +$40.1M | 0.02% | 498 |
|
|
2023
Q3 | $123M | Buy |
6,944,799
+3,053,102
| +78% | +$54.2M | 0.02% | 472 |
|
|
2023
Q2 | $67.5M | Buy |
3,891,697
+1,587,694
| +69% | +$27.5M | 0.01% | 618 |
|
|
2023
Q1 | $54.7M | Buy |
2,304,003
+1,590,432
| +223% | +$37.8M | 0.01% | 662 |
|
|
2022
Q4 | $11.5M | Sell |
713,571
-159,339
| -18% | -$2.57M | ﹤0.01% | 1027 |
|
|
2022
Q3 | $20.4M | Sell |
872,910
-2,350,227
| -73% | -$55M | ﹤0.01% | 893 |
|
|
2022
Q2 | $70.4M | Sell |
3,223,137
-187,682
| -6% | -$4.1M | 0.01% | 769 |
|
|
2022
Q1 | $86.5M | Sell |
3,410,819
-698,904
| -17% | -$17.7M | 0.01% | 779 |
|
|
2021
Q4 | $111M | Sell |
4,109,723
-515,398
| -11% | -$13.9M | 0.01% | 730 |
|
|
2021
Q3 | $121M | Buy |
4,625,121
+245,523
| +6% | +$6.44M | 0.01% | 701 |
|
|
2021
Q2 | $178M | Buy |
+4,379,598
| New | +$178M | 0.02% | 597 |
|